Why the study?
Does growth hormone treatment improve insulin sensitivity and reduce abdominal visceral fat in postmenopausal women with abdominal obesity?
Does growth hormone treatment improve insulin sensitivity and reduce abdominal visceral fat in postmenopausal women with abdominal obesity?
In postmenopausal women with abdominal obesity, 12 months of growth hormone treatment improves insulin sensitivity and reduces visceral fat and atherogenic lipids.
No takes yet. Share an insight, caveat, or question.
Supports GH consideration for metabolic risk reduction in obese postmenopausal women; extends prior data with RCT confirmation of cardiometabolic benefits.
Franco et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: